Table 1.

Number of deaths by cause

Inolimomab (n = 49)Usual care (ATG) (n = 51)
No.%No.%
aGVHD 11 22.4 16 31.4 
cGVHD 4.1 9.8 
Infection 12.2 12 23.5 
Recurrence of initial disease 14.3 
Other 16.3 15.7 
All 34 69.4 41 80.4 
Inolimomab (n = 49)Usual care (ATG) (n = 51)
No.%No.%
aGVHD 11 22.4 16 31.4 
cGVHD 4.1 9.8 
Infection 12.2 12 23.5 
Recurrence of initial disease 14.3 
Other 16.3 15.7 
All 34 69.4 41 80.4 
Close Modal

or Create an Account

Close Modal
Close Modal